-
Featured
Is Accelerated Infliximab Induction Beneficial for Severe Ulcerative Colitis?
While short-interval administration of infliximab was equally efficacious as standard administration for severe ulcerative colitis, a multicenter retrospective study has shown that a higher dose upon initiation reduced the risk of colectomy.
-
Featured
Discovering the Role of C1orf106 in Patients with IBD
C1orf106 is a known susceptibility gene for inflammatory bowel disease, and now Massachusetts General researchers have identified its role: it "fine tunes" the integrity of the intestinal epithelial barrier.
-
Featured
Obesity Tied to Risk of Diverticulosis
By analyzing a cohort of adults who underwent colonoscopy, gastroenterologists at Massachusetts General Hospital have determined that overweight and obesity substantially increase the risk of diverticulosis.
-
AGA Guideline Makes the Case for Biomarkers in Managing Crohn's Disease
Ashwin Ananthakrishnan, MD, discusses the AGA guideline's key recommendations for managing Crohn's disease and the evolving role of biomarkers in these treatments.
-
Fatigue in Inflammatory Bowel Disease Linked to Substantial Economic Burden
Ashwin N. Ananthakrishnan, MBBS, MPH, and colleagues found that healthcare resource utilization was significantly higher for inflammatory bowel disease (IBD) patients with fatigue than those without. The same was true for IBD-related and all-cause medical and pharmacy costs, regardless of IBD subtype or severity.
-
Digital App-based Cognitive Behavioral Therapy Significantly Improves IBS Symptoms
At the American College of Gastroenterology 2023 Scientific Meeting, Mythili Pathipati, MD, presented findings from a real-world study where app-delivered cognitive behavioral therapy resulted in a significant reduction in symptom severity and perceived stress for patients with irritable bowel syndrome.
Bowel Disease Contributors
-
Andrew T. Chan, MD, MPH
Daniel K. Podolsky Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Taking Aspirin Associated With Reduction in Colorectal Cancer Among High-Risk Population
-
Ashwin N. Ananthakrishnan, MBBS, MPH
Director of the Crohn's and Colitis Center, Division of Gastroenterology, Mass General, Associate Professor of Medicine, Harvard Medical School
Recent Article
AGA Guideline Makes the Case for Biomarkers in Managing Crohn's Disease
-
Hamed Khalili, MD, MPH
Gastroenterologist, Clinical and Translational Epidemiology Unit, Director of Clinical Research in Inflammatory Bowel Disease in the Division of Gastroenterology, Associate Professor of Medicine, Harvard Medical School
Recent Article
Initiating Oral Contraception Does Not Change Gut Microbiome in Healthy Women
-
Wenjie Ma, MBBS, ScD
Instructor and Investigator in the Clinical and Translational Epidemiology Unit, Assistant in Epidemiology in the Division of Gastroenterology, Instructor in Medicine, Harvard Medical School
Recent Article
Initiating Screening Before Age 50 Reduces Risk of Colorectal Cancer
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.